— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected.
— Revenues grew 66% to $10.6 million, vs. $8.7 million expected.
— FC2 US prescription net revenues increased 148% to $6.1 million.
— Gross profit increased 57% to $7.3 million.
— VERU shares were up 3.7% in premarket hours on Wednesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Adobe Inc. (ADBE) Stock: Should you invest in this recession-proof tech firm?
Adobe, Inc. (NASDAQ: ADBE) has been dominating the design software space for quite some time, all along staying resilient to macroeconomic fluctuations and market headwinds. The company’s cloud-based applications, offered
Brilliant Earth IPO: Here are a few points to note about this jewelry company that goes public next week
Jewelry has always played a significant role in people’s lives. As life begins to go back to normal after the pandemic and people start attending social events, they are looking
Kontrol Technologies CEO Paul Ghezzi: Our focus is on reinvesting for growth
Tell us about BioCloud, how it’s different from any alternate existing products, and your distribution model. BioCloud exists as a part of Kontrol Technologies and is an innovation within our
